HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

SEURAT-1 Promising, But Still No Non-Animal Systemic-Toxicity Solution

This article was originally published in The Rose Sheet

Executive Summary

The close of the EU's five-year SEURAT-1 program marks "a milestone in the journey to animal-free safety assessment," but "years" of additional work are needed before fully non-animal testing to assess repeated dose systemic toxicity is possible, Cosmetics Europe suggests. Meanwhile, the group says innovation in the sector has taken a hit due to the EU's full ban on cosmetic animal testing, implemented in March 2013.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

RS019776

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel